Objectives Dementia with Lewy bodies (DLB) accounts for 10%–15% of dementia cases at
autopsy and has distinct clinical features associated with earlier institutionalisation and a …

Background Diagnosis of dementia with Lewy bodies (DLB) is challenging, largely due to a
lack of diagnostic tools. Cerebrospinal fluid (CSF) biomarkers have been proven useful in …

Objective: The purpose of this review is to aid primary care providers in distinguishing
dementia with Lewy bodies (DLB) from Alzheimer's disease and from Parkinson's disease …

Abstract Background The DEmEntia with LEwy bOdies Project (DEvELOP) aims to
phenotype patients with dementia with Lewy bodies (DLB) and study the symptoms and …

Objective: Dementia with Lewy bodies is the second most common form of
neurodegenerative dementia in older age yet is often under-recognised and misdiagnosed …

Introduction The recent revision of the consensus diagnostic criteria for dementia with Lewy
bodies (DLB) incorporates an expansive set of core and supportive clinical features …

Introduction: Previous studies on electroencephalography (EEG) to discriminate between
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) have been promising …

Background Differential diagnosis between dementia with Lewy bodies (DLB) and
Alzheimer's disease (AD) is not straightforward, especially in the early stages of disease. We …

Dementia with Lewy bodies (DLB) was considered to be an uncommon cause of dementia
until improved neuropathological staining methods for ubiquitin were developed in the late …

Aim Dementia with Lewy bodies (DLB) is a common but underdiagnosed type of cognitive
impairment and dementia. The current diagnostic criteria for research purposes have a high …